Ligand Reports Second Quarter 2021 Financial Results
Go back to Ligand Reports Second Quarter 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 287.35 -4.42 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $291.77 | 52 Week High | $139.79 | |||
| Open | $291.00 | 52 Week Low | $82.07 | |||
| Day High | $293.51 | P/E | 668.26 | |||
| Day Low | $284.41 | EPS | $0.43 | |||
| Volume | 66,118 | |||||

